Promising New Chronic Lymphocytic Leukemia Treatment Option
A new treatment option called ACP-196 is showing remarkable potential for effectively treating chronic lymphocytic leukemia, or CLL. Researcher Amy Johnson, PhD, explains how a daily pill might completely change the way CLL is treated. Still being studied, ACP-196 has delivered excellent results to date, with 95 percent of patients experiencing favorable results – and with very few side effects – meaning it might be the answer to offering extraordinary outcomes for CLL patients.
Can Chronic Lymphocytic Leukemia be Cured?
Most often, CLL cannot be cured completely; however, new treatment options such as ACP-196 are helping people live for many years while still having the disease. Most people have to experience treatment at some point throughout the course of the disease.
To learn more about other chronic lymphocytic leukemia treatment options or about the disease in general, contact the OSUCCC – James today.